ABVC BioPharma, Inc. (ABVC)
US Market

ABVC BioPharma, Inc. (ABVC) Financial Statements


ABVC BioPharma, Inc. Financial Overview

ABVC BioPharma, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.377; its P/E ratio is -1.76; ABVC BioPharma, Inc. is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 128.27K$ 588.99K$ 42.27K$ 312.86K$ 25.66K
Gross Profit$ 68.04K$ 323.58K$ 31.53K$ 304.49K$ 23.76K
EBIT$ -1.89M$ -3.55M$ -3.65M$ -2.02M$ -6.16M
EBITDA$ -1.89M$ -3.55M$ -3.64M$ -2.01M$ -6.15M
Net Income Common Stockholders$ 2.10M$ -4.86M$ -3.70M$ -1.86M$ -6.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.87M$ 1.47M$ 1.40M$ 2.99M$ 2.81M
Total Assets$ 10.73M$ 9.86M$ 10.48M$ 13.78M$ 12.07M
Total Debt$ 5.21M$ 3.05M$ 3.11M$ 2.87M$ 3.17M
Net Debt$ 3.34M$ 1.59M$ 1.71M$ -124.82K$ 360.34K
Total Liabilities$ 9.00M$ 6.62M$ 4.79M$ 4.60M$ 4.71M
Stockholders Equity$ 1.67M$ 3.10M$ 5.92M$ 9.33M$ 7.43M
Cash Flow-
Free Cash Flow$ -1.50M$ -461.16K$ -518.06K$ -3.45M$ -3.09M
Operating Cash Flow$ -1.50M$ -461.07K$ -513.70K$ -3.43M$ -2.99M
Investing Cash Flow-$ -83.29K$ -1.52M$ -22.03K$ -93.22K
Financing Cash Flow$ 2.21M$ -253.50K$ 603.50K$ 3.66M$ 0.00
Currency in USD

ABVC BioPharma, Inc. Earnings and Revenue History

ABVC BioPharma, Inc. Debt to Assets

ABVC BioPharma, Inc. Cash Flow

ABVC BioPharma, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis